Chemoinformaics analysis of (2-(1-Ethoxyethoxy)ethyl)benzene
| Molecular Weight | 194.274 | nRot | 6 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 6 |
| Exact Molecular Weight | 194.131 | nRing | 1 |
| Solubility: LogS | -2.59 | nHRing | 0 |
| Solubility: LogP | 2.492 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 33.6463 |
| nHD | 0 | BPOL | 21.5297 |
| QED | 0.648 |
| Synth | 2.348 |
| Natural Product Likeliness | 0.154 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.002 |
| HIA | 0.001 |
| CACO-2 | -4.175 |
| MDCK | 0.0000334 |
| BBB | 0.505 |
| PPB | 0.853904 |
| VDSS | 1.349 |
| FU | 0.107276 |
| CYP1A2-inh | 0.231 |
| CYP1A2-sub | 0.623 |
| CYP2c19-inh | 0.275 |
| CYP2c19-sub | 0.776 |
| CYP2c9-inh | 0.099 |
| CYP2c9-sub | 0.298 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.225 |
| CYP3a4-inh | 0.037 |
| CYP3a4-sub | 0.669 |
| CL | 10.893 |
| T12 | 0.529 |
| hERG | 0.052 |
| Ames | 0.177 |
| ROA | 0.018 |
| SkinSen | 0.346 |
| Carcinogencity | 0.618 |
| EI | 0.984 |
| Respiratory | 0.014 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.653643 |